HLA Alleles and the Progression of Human Cryptococcosis
HLA 等位基因与人类隐球菌病的进展
基本信息
- 批准号:10192647
- 负责人:
- 金额:$ 19.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-15 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAllelesAreaAttenuatedBasic ScienceBiological AssayBrainCD4 Positive T LymphocytesCell CountCellsCerebrospinal FluidCessation of lifeCharacteristicsClinicalClinical SciencesCommunicable DiseasesCryptococcal MeningitisCryptococcosisCryptococcusCryptococcus neoformansDataDevelopmentDiseaseDisease ProgressionFoundationsFunctional disorderFutureGTP-Binding Protein alpha Subunits, GsGene FrequencyGeneral PopulationGenesGeneticHIVHIV InfectionsHLA AntigensHealth systemHelper-Inducer T-LymphocyteHistocompatibility Antigens Class IIHumanImmuneImmune responseImmune systemImmunityImmunocompromised HostImmunologicsImmunologyImmunophenotypingImpairmentIndividualInfectionInterferon Type IIKnowledgeLungMaintenanceMajor Histocompatibility ComplexMediatingMeningitisMethodsModalityMusMycosesNeurologicOutcomeParticipantPathway interactionsPeptidesPersonsPopulationPrevalenceProgressive DiseaseProteinsResearchRiskRoleStudy modelsSystemT cell responseT-LymphocyteTechnologyTestingTh2 CellsTherapeuticUgandaViral Load resultYeastsbasecell mediated immune responsecohortcytokinedisorder controldisorder riskhealthy volunteerimprovedinnovationinterestknowledge basepathogenic funguspersonalized medicinepolarized cellresponsestudy populationvaccine development
项目摘要
Project Summary
Cryptococcus continues to cause significant disease in immunocompromised individuals, particularly
those with HIV/AIDS. Understanding the interplay between the human immune system and this
pathogenic fungus is critical if we hope to improve clinical outcomes. The overall scientific objective of
the research is to understand how the immune system in humans is directed towards a protective or
deleterious response in Cryptococcus infection, while the specific objective of this proposal is to
determine factors that impact the helper T cell response in humans during cryptococcal meningitis.
Notably, there is particular interest in how the HLA/MHC system influences CD4+ T cells in their
response to Cryptococcus. To accomplish this, the first aim is to identify the most prevalent HLA
alleles in persons with cryptococcal disease. The hypothesis is that certain HLA alleles are
associated with developing progressive disease, while others are associated with attenuating or
protecting against disease. Establishing HLA-disease associations not only carries important clinical
and therapeutic implications, but creates the knowledge base for further immunological studies. Aim
two will use immunophenotyping modalities to determine helper T cell responses in the cryptococcal-
specific immune response. The use of CD4+ T cell tetramers on cells from HIV-infected humans
provides a proof-of-concept model for the study of infectious disease-specific T cell responses going
forward. Additionally, performing activation induced marker (AIM) assays on the same cohort will
provide a comparator method in the testing of the hypothesis that Th1 helper T responses are more
protective in cryptococcosis than Th2 responses. The data generated by this study will drive
innovation in the areas of vaccine development, personalized medicine, and health systems
implementation. By establishing the necessary data on HLA prevalence of our study population and
successfully implementing our proposed immunology methods to determine disease-specific T cell
responses, we will lay the foundation for future clinical and basic science studies to understand how
the human immune system responds to infection with Cryptococcus and manipulate that response to
reduce disease.
项目摘要
隐球菌继续在免疫功能受损的人中引起重大疾病,特别是
那些感染艾滋病毒/艾滋病的人。了解人类免疫系统与此之间的相互作用
如果我们希望改善临床结果,病原真菌是至关重要的。总的科学目标是
这项研究是为了了解人类的免疫系统是如何针对一种保护性或
对隐球菌感染的有害反应,而这项提议的具体目标是
确定在隐球菌性脑膜炎期间影响人类辅助T细胞反应的因素。
值得注意的是,人们特别感兴趣的是,人类白细胞抗原/巨噬细胞集落刺激因子系统如何影响体内的CD4+T细胞。
对隐球菌的反应。要做到这一点,第一个目标是确定最普遍的人类白细胞抗原
隐球菌病患者的等位基因。假设某些人类白细胞抗原等位基因是
与发展为进展性疾病有关,而另一些则与衰弱或
预防疾病。建立人类白细胞抗原疾病关联不仅具有重要的临床意义
和治疗意义,但为进一步的免疫学研究创造了知识基础。目标
其中两个将使用免疫表型方法来确定隐球菌中的辅助T细胞反应-
特异性免疫反应。CD4+T细胞四聚体在HIV感染者细胞上的应用
为传染病特异性T细胞反应的研究提供了概念验证模型
往前走。此外,在同一队列上执行激活诱导标记(AIM)分析将
提供了一种检验Th1辅助T反应更多的假设的比较器方法
对隐球菌病的保护作用优于Th2反应。这项研究产生的数据将推动
疫苗开发、个性化医疗和卫生系统领域的创新
实施。通过建立我们研究人群中人类白细胞抗原流行率的必要数据
成功实施我们提出的免疫学方法来确定疾病特异性T细胞
我们将为未来的临床和基础科学研究奠定基础,以了解
人类免疫系统对感染隐球菌做出反应,并操纵这种反应
减少疾病。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The interplay of phenotype and genotype in Cryptococcus neoformans disease.
- DOI:10.1042/bsr20190337
- 发表时间:2020-10-30
- 期刊:
- 影响因子:4
- 作者:Altamirano S;Jackson KM;Nielsen K
- 通讯作者:Nielsen K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kirsten Nielsen其他文献
Kirsten Nielsen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kirsten Nielsen', 18)}}的其他基金
Impact of Cryptococcus Titan Cells on Pathogenesis.
隐球菌泰坦细胞对发病机制的影响。
- 批准号:
9897466 - 财政年份:2018
- 资助金额:
$ 19.3万 - 项目类别:
Impact of Cryptococcus Titan Cells on Pathogenesis.
隐球菌泰坦细胞对发病机制的影响。
- 批准号:
10371091 - 财政年份:2018
- 资助金额:
$ 19.3万 - 项目类别:
Control of cryptococcal infection through manipulation of the host immune response.
通过操纵宿主免疫反应来控制隐球菌感染。
- 批准号:
9198749 - 财政年份:2016
- 资助金额:
$ 19.3万 - 项目类别:
Pheromones and Titan Cell Production in Cryptococcus neoformans
新型隐球菌中的信息素和泰坦细胞产生
- 批准号:
8069791 - 财政年份:2011
- 资助金额:
$ 19.3万 - 项目类别:
Pheromones and Titan Cell Production in Cryptococcus neoformans
新型隐球菌中的信息素和泰坦细胞产生
- 批准号:
8602794 - 财政年份:2011
- 资助金额:
$ 19.3万 - 项目类别:
Pheromones and Titan Cell Production in Cryptococcus neoformans
新型隐球菌中的信息素和泰坦细胞产生
- 批准号:
8788248 - 财政年份:2011
- 资助金额:
$ 19.3万 - 项目类别:
Pheromones and Titan Cell Production in Cryptococcus neoformans
新型隐球菌中的信息素和泰坦细胞产生
- 批准号:
8225165 - 财政年份:2011
- 资助金额:
$ 19.3万 - 项目类别:
Pheromones and Titan Cell Production in Cryptococcus neoformans
新型隐球菌中的信息素和泰坦细胞产生
- 批准号:
8417740 - 财政年份:2011
- 资助金额:
$ 19.3万 - 项目类别:
A link between mating pheromone sensing and virulence of Cryptococcus neoformans
交配信息素感应与新生隐球菌毒力之间的联系
- 批准号:
7425136 - 财政年份:2008
- 资助金额:
$ 19.3万 - 项目类别:
A link between mating pheromone sensing and virulence of Cryptococcus neoformans
交配信息素感应与新生隐球菌毒力之间的联系
- 批准号:
7678001 - 财政年份:2008
- 资助金额:
$ 19.3万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 19.3万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 19.3万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 19.3万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 19.3万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 19.3万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 19.3万 - 项目类别:
Studies on cofactors for development of acquired immunodeficiency syndrome in feline immunodeficiency virus infection.
猫免疫缺陷病毒感染后获得性免疫缺陷综合征发生的辅助因子研究。
- 批准号:
03660315 - 财政年份:1991
- 资助金额:
$ 19.3万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 19.3万 - 项目类别:














{{item.name}}会员




